Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model

PURPOSE: Pathologic corneal neovascularization is a major cause of blindness worldwide, and treatment options are currently limited. VEGF is one of the critical mediators of corneal neovascularization but current anti-VEGF therapies have produced limited results in the cornea. Thus, additional thera...

Full description

Saved in:
Bibliographic Details
Published in:Invest Ophthalmol Vis Sci
Main Authors: Sun, Michel M., Chan, Ann M., Law, Samuel M., Duarte, Sergio, Diaz-Aguilar, Daniel, Wadehra, Madhuri, Gordon, Lynn K.
Format: Artigo
Language:Inglês
Published: The Association for Research in Vision and Ophthalmology 2019
Subjects:
Cornea
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6336205/
https://ncbi.nlm.nih.gov/pubmed/30646013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.18-24345
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items